Concepedia

Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis

Wouter H Bos, G. M. Bartelds, Marijn Vis, A. R. van der Horst, Gertjan Wolbink, R J van de Stadt, Dirkjan van Schaardenburg, Ben A. C. Dijkmans, Willem F. Lems, Michael T. Nurmohamed,

Annals of the Rheumatic Diseases · 2008 · 32 citations · 34 references

DOIFull text

Open access

Concepts

References

34

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

Solbritt Rantapää‐Dahlqvist, B.A.W. de Jong, Ewa Berglin et al. · Arthritis & Rheumatism · 2003 · 2K citations

, , +17

Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors

Markus M. J. Nielen, Dirkjan van Schaardenburg, H. W. Reesink et al. · Arthritis & Rheumatism · 2004 · 1.8K citations · Full text

, , +17

Development and validation of the european league against rheumatism response criteria for rheumatoid arthritis: Comparison with the preliminary american college of rheumatology and the world health organization/international league against rheumatism criteria

Anke M. van Gestel, M.L.L. Prevoo, Martin A. van't Hof et al. · Arthritis & Rheumatism · 1996 · 1.6K citations

, , +17

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.

Gerard A. Schellekens, Brigit A. de Jong, F.H.J. van den Hoogen et al. · Journal of Clinical Investigation · 1998 · 1.4K citations · Full text

, , +17

Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response.

R.C. Aalberse, R. van der Gaag, J. van Leeuwen · The Journal of Immunology · 1983 · 740 citations

, , +17